Markets:

Overview

News

Currencies

International

Treasuries

Globus Medical, Inc. Class A Common Stock (NY:GMED)

92.52 -2.12 (-2.24%)

Official Closing Price Updated: 7:00 PM EST, Jan 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

These stocks are gapping in today's session ↗

November 07, 2025

The market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

GMED Q3 Deep Dive: U.S. Spine Momentum and Nevro Integration Drive Upbeat Results

November 07, 2025

Medical device company Globus Medical (NYSE:GMED) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 22.9% year on year to $769 million. The company’s full-year revenue guidance of...

Via StockStory

Here's What Stimulated Global Medical's Third-Quarter Blowout ↗

November 07, 2025

The company wrapped its acquisition of a spinal cord stimulating company earlier this year.

Via Investor's Business Daily

This Expedia Group Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday ↗

November 07, 2025

Via Benzinga

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

A Preview Of Globus Medical's Earnings ↗

November 05, 2025

Via Benzinga

Discover the top movers in Friday's pre-market session. ↗

November 07, 2025

As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 07, 2025

Via Benzinga

Globus Medical Inc (NYSE:GMED) Stock Surges on Strong Q3 2025 Earnings Beat and Raised Guidance ↗

November 06, 2025

Globus Medical's Q3 2025 earnings crushed estimates, with EPS of $1.18 beating by 47%. The stock surged over 22% as the company also raised its full-year profit guidance.

Via Chartmill

Topics Earnings

Globus Medical’s (NYSE:GMED) Q3: Strong Sales, Stock Jumps 19.2%

November 06, 2025

Medical device company Globus Medical (NYSE:GMED) announced better-than-expected revenue in Q3 CY2025, with sales up 22.9% year on year to $769 million. The company’s full-year revenue guidance of...

Via StockStory

What's going on in today's after hours session ↗

November 06, 2025

Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

Globus Medical Reports Third Quarter 2025 Results

November 06, 2025

From Globus Medical

Via GlobeNewswire

Globus Medical (GMED) Q3 Earnings: What To Expect

November 04, 2025

Medical device company Globus Medical (NYSE:GMED) will be reporting results this Thursday after market hours. Here’s what investors should know.

Via StockStory

2 Growth Stocks with All-Star Potential and 1 We Find Risky

October 30, 2025

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who...

Via StockStory

Topics Electric Vehicles

Paradice Dumped Its Entire $15.2 Million Progressive Software Stake ↗

October 26, 2025

Paradice Dumped Its Entire $15.2 Million Progressive Software Stake

Via The Motley Fool

Globus Medical Schedules Third Quarter Earnings Release and Conference Call

October 16, 2025

From Globus Medical

Via GlobeNewswire

Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma

October 14, 2025

From Globus Medical

Via GlobeNewswire

Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

Winners And Losers Of Q2: Globus Medical (NYSE:GMED) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks

October 06, 2025

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including Globus Medical (NYSE:GMED) and its peers.

Via StockStory

3 Cash-Producing Stocks Worth Your Attention

October 06, 2025

Businesses with strong free cash flow tend to be more adaptable and resilient. Some of these companies shine bright by using their cash wisely to strengthen their market positions.

Via StockStory

1 Cash-Heavy Stock with Exciting Potential and 2 That Underwhelm

October 02, 2025

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining...

Via StockStory

2 Reasons to Watch GMED and 1 to Stay Cautious

October 01, 2025

Globus Medical’s stock price has taken a beating over the past six months, shedding 21.5% of its value and falling to $57.60 per share. This may have investors wondering how to approach the situation.

Via StockStory

Topics Government World Trade

Growth Titans: Eli Lilly's Weight-Loss Surge vs. Johnson & Johnson's Diversified Might

September 22, 2025

The pharmaceutical landscape is currently a tale of two giants employing vastly different, yet highly successful, growth strategies. Eli Lilly and Company (NYSE: LLY) has placed an extraordinary bet on...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

2 of Wall Street’s Favorite Stocks with Promising Prospects and 1 We Question

September 22, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

1 Small-Cap Stock with Solid Fundamentals and 2 Facing Headwinds

September 17, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc.

August 28, 2025

From Globus Medical

Via GlobeNewswire

Sherwin-Williams, Sealed Air, Super Micro, Globus Medical, and Haemonetics Stocks Trade Up, What You Need To Know

August 22, 2025

A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested...

Via StockStory

Topics ETFs Economy

Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage ↗

August 18, 2025

Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a $16 target.

Via Benzinga

Globus Medical Inc - A (NYSE:GMED): A Prime Example of Affordable Growth with Strong Fundamentals ↗

August 15, 2025

Globus Medical (GMED) exemplifies Affordable Growth investing with strong revenue/earnings growth, reasonable valuation, and solid profitability—ideal for GARP-focused investors.

Via Chartmill

1 Cash-Producing Stock Worth Your Attention and 2 We Find Risky

August 13, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Globus Medical, Inc. Class A Common Stock (NY:GMED)

All News about Globus Medical, Inc. Class A Common Stock

Starting at $3.75/week.

Subscribe Today